After three straight years of 10% or greater returns for the S&P 500, gains in year four are typically more subdued. But that ...

"Researchers told us they were spending hours each week manually checking vendor websites for restocks and price changes," said Bob Vidra, founder of PeptideCritic. "Our new tracking system puts that ...

Robust second-quarter earnings have eased investor concerns about the health of the US economy. Based on these positive events, Jefferies have raised its year-end target for the S&P 500 index to 6,600 ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

General Motors is on track to end 2025 as the top US-traded automaker stock – far outpacing American rivals like Ford, Tesla ...

Table by author. Data source: YCharts. Eli Lilly's stock highlights one of the big risks with investing in a stock that's trading at a high valuation -- expectations are also elevated. It's normally ...

Pentair is only one year away from potentially becoming a Dividend King. The stock's performance has beaten the S&P 500 hands down over the last five years. Pentair could be appealing to investors ...

What's notable, however, is that only once during that stretch has the stock been down more than 20% in a single year -- that was back in 2022. As interest rates were on the rise and inflation was a ...

A new stock tracking index is betting that Taylor Swift can not only buy back her masters, release yet another album and find true love — but also move markets. After the pop star got engaged to ...

Two Phase 3 real-world trials, conducted on boats, showed that NEREUS significantly reduced vomiting compared with placebo.

Back in January, DeepSeek sparked a frenzy in the tech landscape with its R1 model, and now it has returned to ignite a debate once again. According to the AI startup, it spent $294,000 on training ...